Bone marrow NK1.1- and NK1.1+ T cells reciprocally regulate acute graft versus host disease

被引:251
作者
Zeng, DF
Lewis, D
Dejbakhsh-Jones, S
Lan, FS
García-Ojeda, M
Sibley, R
Strober, S
机构
[1] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
关键词
bone marrow transplantation; immune regulation; regulatory T cells; cytokines; interleukin; 4;
D O I
10.1084/jem.189.7.1073
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sorted CD4(+) and CD8(+) T cells from the peripheral blood or bone marrow of donor C57BL/6 (H-2(b)) mice were tested for their capacity to induce graft-versus-host disease (GVHD) by injecting the cells, along with stringently T cell-depleted donor I-narrow cells, into lethally irradiated BALB/c (H-2(d)) host mice. The peripheral blood T cells were at least 30 times more potent than the marrow T cells in inducing lethal GVHD. As NK1.1(+) T cells represented <1% of all T cells in the blood and similar to 30% of T cells in the marrow, the capacity of sorted marrow NK1.1(-) CD4(+) and CD8(+) T cells to induce GVHD was tested. The latter cells had markedly increased potency, and adding back marrow NK1.1(+) T cells suppressed GVHD. The marrow NK1.1(+) T cells secreted high levels of both interferon gamma (IFN-gamma) and interleukin 4 (IL-4), and the NK1.1(-) T cells secreted high levels of IFN-gamma with little IL-4. Marrow NK1.1(+) T cells obtained from IL-4(-/-) rather than wild-type C57BL/6 donors not only failed to prevent GVHD but actually increased its severity. Together, these results demonstrate that GVHD is reciprocally regulated by the NK1.1(-) and NK1.1(+) T cell subsets via their differential production of cytokines.
引用
收藏
页码:1073 / 1081
页数:9
相关论文
共 43 条
  • [1] THE EFFECT OF PERIPHERAL LYMPHOID-CELLS ON THE INCIDENCE OF LETHAL GRAFT VERSUS HOST-DISEASE FOLLOWING ALLOGENEIC MOUSE BONE-MARROW TRANSPLANTATION
    ALMARAZ, R
    BALLINGER, W
    SACHS, DH
    ROSENBERG, SA
    [J]. JOURNAL OF SURGICAL RESEARCH, 1983, 34 (02) : 133 - 144
  • [2] NK1.1+ CD4+ CD8- THYMOCYTES WITH SPECIFIC LYMPHOKINE SECRETION
    ARASE, H
    ARASE, N
    NAKAGAWA, K
    GOOD, RA
    ONOE, K
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) : 307 - 310
  • [3] BATINIC D, 1990, BONE MARROW TRANSPL, V6, P103
  • [4] Association between alpha beta TCR(+)CD4(-)CD8(-) T-cell deficiency and IDDM in NOD/Lt mice
    Baxter, AG
    Kinder, SJ
    Hammond, KJL
    Scollay, R
    Godfrey, DI
    [J]. DIABETES, 1997, 46 (04) : 572 - 582
  • [5] Mouse CD1-specific NK1 T cells: Development, specificity, and function
    Bendelac, A
    Rivera, MN
    Park, SH
    Roark, JH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 535 - 562
  • [6] BROK HPM, 1993, J IMMUNOL, V151, P6451
  • [7] BROSS DS, 1984, BLOOD, V63, P1265
  • [8] BURNETT AK, 1988, LEUKEMIA, V2, P300
  • [9] Ellison CA, 1998, J IMMUNOL, V161, P631
  • [10] Requirements for CD1d recognition by human invariant V alpha 24(+) CD4(-)CD8(-) T cells
    Exley, M
    Garcia, J
    Balk, SP
    Porcelli, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 109 - 120